| Pharmaceutical active ingredients: |
| Reserpine |
| Available forms, composition and doses of Eskaserpine: |
| N / A |
| Eskaserpine medical category: |
| Human:Peripheral adrenergic inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AA02 - Reserpine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eskapar | Nifuroxazide | Armstrong Laboratorios de Mexico |
| Eskapar Compuesto | Metronidazole; Nifuroxazide | Armstrong Laboratorios de Mexico |
| Eskapen | Vitamin B1 | Unidentified Pharmaceutical Company |
| Eskaphen | Vitamin B1 | Unidentified Pharmaceutical Company |
| Eskaserp | Reserpine | Unidentified Pharmaceutical Company |
| Eskatrol | Prochlorperazine | Unidentified Pharmaceutical Company |
| Eskaycillin | Ampicillin | GlaxoSmithKline |
| Eskazine | Trifluoperazine Hydrochloride | Goldshield Pharmaceuticals |
| Eskazinyl | Trifluoperazine | Unidentified Pharmaceutical Company |
| Eskazole | Albendazole | GlaxoSmithKline; Armstrong Laboratorios de Mexico; Institute of Pharmaceutical Research and Technology |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eskadiazine | Sulfadiazine | Unidentified Pharmaceutical Company |
| Eskalin | Virginiamycin | Unidentified Pharmaceutical Company |
| Eskapen | Vitamin B1 | Unidentified Pharmaceutical Company |
| Eskaphen | Vitamin B1 | Unidentified Pharmaceutical Company |
| Eskaserp | Reserpine | Unidentified Pharmaceutical Company |
| Eskatrol | Prochlorperazine | Unidentified Pharmaceutical Company |
| Eskazinyl | Trifluoperazine | Unidentified Pharmaceutical Company |
| Eskel | Kellin | Unidentified Pharmaceutical Company |
| Esmail | Medazepam | Unidentified Pharmaceutical Company |
| Esmind | Promazine | Unidentified Pharmaceutical Company |